StockData
CannaPharmaRx, Inc. logo

CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 17, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.54MP/E –Yield –

CannaPharmaRx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

CannaPharmaRx's gross profit for the twelve months ending Sep 30, 2026 was -$1.54M. For fiscal 2025 it was -$2.08M.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.08M–
FY2024Dec 31, 2024-$2.93M–
FY2023Dec 31, 2023$0–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$277.78K–
Q2 FY2026Jun 30, 2026-$138.45K–
Q1 FY2026Mar 31, 2026-$409.45K–
Q4 FY2025Dec 31, 2025-$716.99K–
Q3 FY2025Sep 30, 2025-$373.71K–
Q2 FY2025Jun 30, 2025-$621.21K–
Q1 FY2025Mar 31, 2025-$502.61K–
Q4 FY2024Dec 31, 2024-$1.69M–
Q3 FY2024Sep 30, 2024-$356.16K–
Q2 FY2024Jun 30, 2024-$171.36K–
Q1 FY2024Mar 31, 2024-$437.41K–
Q4 FY2023Dec 31, 2023$0–
Q3 FY2023Sep 30, 2023$0–
Q2 FY2023Jun 30, 2023$0–
Q1 FY2023Mar 31, 2023$0–

More CannaPharmaRx figures

See a number that looks wrong?